Patent · US Expired

Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

US6558932B1 · kind B1 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 3, 2000
Grant dateMay 6, 2003
Priority date
Expiry dateNov 3, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a novel gene, gridlock, and its encoded protein. gridlock plays a role in vascular development and modeling, and a mutation in gridlock has been associated with an aortic arch disease, coarctation. Thus, gridlock nucleic acid molecules and polypeptides can be used in methods of diagnosing, treating, and preventing gridlock-related diseases and conditions, such as aortic arch diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.